Anti-NGF x Anti-TNF Bispecific Antibody (IgG-IgG) (BSIG-182)

Anti-NGF x Anti-TNF Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-NGF and anti-TNF parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Osteoarthritis therapy.

Datasheet INQUIRY

Specifications

Targets

NGF & TNF

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Osteoarthritis

Targets

Target 1

NGF

Gene ID

4803

UniProt ID

P01138

Alternative Names

nerve growth factor; NGF; NGFB; HSAN5; Beta-NGF; beta-nerve growth factor

Target 2

TNF

Gene ID

7124

UniProt ID

P01375

Alternative Names

TNF; tumor necrosis factor; DIF; TNFA; TNFSF2; TNF-alpha; TNFα; cachectin; APC1 protein; TNF, monocyte-derived; TNF-α; TNF, macrophage-derived; tumor necrosis factor-alpha; tumor necrosis factor ligand superfamily member 2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-NGF x Anti-TNF Bispecific Antibody (IgG-IgG) (BSIG-182). Click the button below to contact us or submit your feedback about this product.

Anti-NGF x Anti-TNF Bispecific Antibody (IgG-IgG) (CAT#: BSIG-182)

Specifications

Targets

Customer Reviews and Q&As